Genetic control of chemokines in severe human internal carotid artery stenosis

Cytokine

Volumn 41, Issue 1, 2008, Pages 24-28

  Ghilardi, Giorgio ^a   Biondi, Maria Luisa ^b   Turri, Olivia ^b   Pateri, Francesca ^b   d'Eril, Gianvico Melzi ^a,b   Scorza, Roberto ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN PAOLO HOSPITAL   (Italy)

Author keywords

Atherosclerosis; Chemokines; Internal carotid artery; Polymorphisms

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; STROMAL CELL DERIVED FACTOR 1;

ADULT; AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC REGULATION; GENOTYPE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INFLAMMATION; INTERNAL CAROTID ARTERY OCCLUSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS;

AGED; ALLELES; ATHEROSCLEROSIS; CAROTID ARTERY, INTERNAL; CAROTID STENOSIS; CHEMOKINES; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, CHEMOKINE; RISK FACTORS;

EID: 37349049624     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2007.10.007     Document Type: Article

References (41)

1. Libby P. Molecular bases of the acute coronary syndrome. Circulation 91 (1995) 2844-2850
2. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 340 (1999) 115-126
3. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol 57 (1995) 791-804
4. Gerrity R.G. The role of monocyte in atherogenesis, I: transition of blood-borne monocytes into foam cells in fatty lesion. Am J Pathol 103 (1981) 181-190
5. Murdoch C., and Finn A. Chemokine receptors and their role in inflammation and infectious. Blood 95 (2000) 3032-3043
6. Nelken N.A., Coughlin S.R., Gordon D., and Wilcox J.N. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 88 (1991) 1121-1127
7. Abi-Younes S., Sauty A., Mach F., Sukhova G.K., Libby P., and Luster A.D. The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques. Circ Res 86 (2000) 131-138
8. Schall T.J., Bacon K., Toy K.J., and Goeddel D.V. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347 (1990) 669-671
9. von Hundelshausen P., Weber K.S., Huo Y., Proudfoot A.E., Nelson P.J., Ley K., et al. RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation 103 (2001) 1772-1777
10. Yun J.J., Fischbein M.P., Laks H., Irie Y., Espejo M.L., Fishbein M.C., et al. RANTES production during development of cardiac allograft vasculopathy. Transplantation 71 (2001) 1649-1656
11. Veillard N.R., Kwak B., Pelli G., Mulhaupt F., James R.W., Proudfoot A.E., et al. Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice. Circ Res. 94 (2004) 253-261
12. Grewal I.S., Rutledge B.J., Fiorillo J.A., Gu L., Gladue R.P., Flavell R.A., et al. Transgenic monocyte chemoattractant protein-1 (MCP-1) in pancreatic islets produces monocyte-rich insulitis without diabetes: abrogation by a second transgene expressing systemic MCP-1. J Immunol 159 (1997) 401-408
13. Furukawa Y., Matsumori A., Ohashi N., Shioi T., Ono K., Harada A., et al. Anti-monocyte chemoattractant protein-1/monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteries. Circ Res 84 (1999) 306-314
14. Abi-Younes S., Sauty A., Mach F., Sukhova G.K., Libby P., and Luster A.D. The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques. Circ Res 86 (2000) 131-138
15. Bursill C.A., Channon K.M., and Greaves D.R. The role of chemokines in atherosclerosis: recent evidence from experimental models and population genetics. Curr Opin Lipidol 15 (2004) 145-149
16. North American Symptomatic Carotid Endarterectomy Trial Collaborators: Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325:445-53.
17. European Carotid Surgery Trialist's Collaborative Group: Randomized trial of endarterectomy for symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998;351:1379-87.
18. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study: endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995;273:1421-8.
19. The European Carotid Surgery Trialist's Collaborative Group: risk of stroke in the distribution of an asymptomatic carotid artery. Lancet 1995;345:209-12.
20. Golledge J., Greenhalgh R.M., and Davies A.H. The symptomatic carotid plaque. Stroke 31 (2000) 774-781
21. Rothwell P.M. Carotid artery disease and the risk of ischaemic stroke and coronary vascular events. Cerebrovasc Dis 10 suppl 5 (2000) 21-33
22. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., et al. The National High Blood Pressure Education Program Coordinating Committee: Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42 (2003) 1206-1252
23. Naylor A.R., and Rothwell P.M. Bell PRF: Overview of the principal results and secondary analyses from the European and North American randomised trials of endarterectomy for symptomatic carotid stenosis. Eur J Vasc Endovasc Surg 26 (2003) 115-129
24. Rothwell P.M., Gutnikov S.A., and Warlow C.P. Reanalysis of the final results of the European Carotid Surgery Trial. Stroke 34 (2003) 514-523
25. Biller J., Feinberg W.M., Castaldo J.E., Whittemore A.D., Harbaugh R.E., Dempsey R.J., et al. Guidelines for carotid endarterectomy. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Circulation 97 (1998) 501-509
26. Stary H.C., Chandler A.B., Dinsmore R.E., Fuster V., Glagov S., Insull Jr. W., et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on vascular lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 92 (1995) 1355-1374
27. De Monti M., Ghilardi G., Caverni L., Ceriani L., Soldi S., Massaro F., et al. Multidetector helical angio CT oblique reconstructions orthogonal to internal carotid artery for preoperative evaluation of stenosis. Minerva Cardioangiol 51 (2003) 373-385
28. Ghilardi G., Biondi M.L., La Torre A., Battaglioli L., and Scorza R. Breast cancer progression and host polymorphisms in the chemokine system: role of the Macrophage Chemoattractant Protein-1 (MCP-1) -2518 G Allele. Clin Chem 51 (2005) 452-455
29. Winkler C., Modi W., Smith M.W., Nelson G.W., Wu X., Carrington M., et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 279 (1998) 389-393
30. Benboubker L., Watier H., Carion A., Georget M.T., Desbois I., Colombat P., et al. Association between the SDF1-3′A allele and high levels of CD34(+) progenitor cells mobilized into peripheral blood in humans. Br J Haematol 113 (2001) 247-250
31. Soriano A., Martinez C., Garcia F., Plana M., Palou E., Lejeune M., et al. Plasma stromal cell-derived factor (SDF)-1 levels, SDF1-3′A genotype, and expression of CXCR4 on T lymphocytes: their impact on resistance to human immunodeficiency virus type 1 infection and its progression. J Infect Dis 186 (2002) 922-931
32. Nickel R.G., Casolaro V., Wahn U., Beyer K., Barnes K.C., Plunkett B.S., et al. Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J Immunol 164 (2000) 1612-1616
33. Makki R.F., al Sharif F., Gonzalez-Gay M.A., Garcia-Porrua C., Ollier W.E., and Hajeer A.H. RANTES gene polymorphism in polymyalgia rheumatica, giant cell arteritis and rheumatoid arthritis. Clin Exp Rheumatol 18 (2000) 391-393
34. Nakajima K., Tanaka Y., Nomiyama T., Ogihara T., Ikeda F., Kanno R., et al. RANTES promoter genotype is associated with diabetic nephropathy in type 2 diabetic subjects. Diabetes Care 26 (2003) 892-898
35. Simeoni E., Winkelmann B.R., Hoffmann M.M., Fleury S., Ruiz J., Kappenberger L., et al. Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis. Eur Heart J 25 (2004) 1438-1446
36. Valdes A.M., Wolfe M.L., O'Brien E.J., Spurr N.K., Gefter W., Rut A., et al. Val64Ile polymorphism in the C-C chemokine receptor 2 is associated with reduced coronary artery calcification. Arterioscler Thromb Vasc Biol 22 (2002) 1924-1928
37. Szalai C., Duba J., Prohaszka Z., Kalina A., Szabo T., Nagy B., et al. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD) Coincidence of elevated Lp(a) and MCP-1-2518 G/G genotype in CAD patients. Atherosclerosis 158 (2001) 233-239
38. Brenner D., Labreuche J., Touboul P.J., Schmidt-Petersen K., Poirier O., Perret C., et al. on behalf of the GENIC Investigators Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis. Stroke 37 (2006) 1691-1696
39. Tabara T., Kohara K., Yamamoto Y., Igase M., Nakura J., Kondo I., et al. Polymorphism of the monocyte chemoattractant protein (MCP-1) gene is associated with the plasma level of MCP-1 but not with carotid intima-media thickness. Hypertension Res 26 (2003) 677-683
40. Ghilardi G., Biondi M.L., Battaglioli L., Zambon A., Guagnellini E., and Scorza R. Genetic risk factor characterizes abdominal aortic aneurysm from arterial occlusive disease in human beings: CCR5 Δ32 deletion. J Vasc Surg 40 (2004) 995-1000
41. Gonzalez P., Alvarez R., Batalla A., Reguero J.R., Alvarez V., Astudillo A., et al. Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infraction. Genes Immunity 2 (2001) 191-195